- Global Pharma News & Resources

Cancer Biological Therapy Market Size in USD 33.9 Billion to Accelerate at 11.9% CAGR Through 2031

Pune, Maharashtra, India, November 9 2022 (Wiredrelease) Prudour Pvt. Ltd –:Cancer biological therapy is the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat cancer. There are four major types of cancer biological therapy: immunotherapy, monoclonal antibodies, targeted therapy, and gene therapy. Immunotherapy helps the body’s immune system fight cancer. Monoclonal antibodies are man-made versions of immune system proteins that can locate and attach to cancer cells.

Cancer is one of the most prevalent diseases globally with approximately 14.1 million new cases and 8.2 million cancer-related deaths reported in 2012 alone. According to a report by Research, the global cancer biological therapy market was valued at USD 16.4 billion in 2011 and is expected to grow to USD 33.9 billion by 2018, at a CAGR of 11.9% from 2011 to 2018.

Cancer biological therapy includes the use of living cells or components thereof for the treatment of cancer. Cancer biological therapies can be used alone or in combination with other cancer treatments such as surgery, chemotherapy, and radiation therapy. The most common types of cancer biological therapies are monoclonal antibodies, immune system modulators, oncolytic viruses, and tumor vaccines.

The Cancer Biological Therapy Market size was valued at USD 77 Billion in 2021 and is projected to reach USD 136.6 Billion by 2031, growing at a CAGR of 7% from 2022 to 2031.

Request a sample copy of the Cancer Biological Therapy Market Report:

We offer a sample report that includes the following:

1. Overview, Industry Analysis, and Introduction are all included in the 2022 update report.

2. The package contains the COVID-19 Pandemic Impact Analysis.

3. Provide chapter-by-chapter guidance regarding the Request

4. An Updated Regional Analysis Using a Graphical Representation Of Size, Share, and Trends For The Year 2022

5. Tables & Figures have been updated

6. The latest version of this report includes the Top Market Participants, their Business Strategies SWOT Analysis, and Historical Growth.

7. Facts, Factors Research Methodology

(Please note that this report includes the COVID-19 impact study. )

The cumulative impact of the Russia-Ukraine conflict 2022:

We monitor and update all reports regarding political and economic uncertainties arising from the Russian invasion of Ukraine. It is possible to see negative consequences worldwide, especially in Eastern Europe, Eastern & Central Asia, and the United States. This has caused severe disruptions in trade dynamics and negatively affected livelihoods and lives. The uncertainty and war in Eastern Europe will hurt the global economy. Russia is particularly vulnerable. This report details the potential impact of price & supply, pricing variants, and strategic uptake of vendors. It also makes recommendations for the Cancer Biological Therapy market based on the current update regarding the conflict and its global responses.

Some of the major players in the Cancer Biological Therapy market are:

ELI Lilly
Novartis International
Bristol-Myers Squibb
Seattle Genetics
Takeda Pharmaceuticals
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.

Segmentation Overview:


Monoclonal Antibodies
Cancer Growth Blockers
Blood Cell Growth Factors


Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies

Regional/Geographically study:

1. North America (United States, Canada, and Mexico)

2. Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)

3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia, Indonesia, Malaysia, Singapore, Taiwan, etc.)

4. South America (Brazil, Argentina, Columbia, etc.)

5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

For inquiry click here@:

The report contains insights about the following:

1. Market Penetration: provides comprehensive information on the market, including the key players

2. Market Development: Provides detailed information about profitable emerging markets and analyses penetration across the mature markets

3. Market Diversification: Information about new product launches and untapped geographies is provided. Recent developments.

4. Competitive Assessment and Intelligence: This comprehensive report analyzes market shares, strategies, and products, as well as certifications, regulatory approvals, patent landscapes, and manufacturing capabilities for the top players.

5. Product Development & Innovation: Provides smart insights about future technologies, R&D activities as well as breakthrough product developments

Reasons to Purchase this Report:

1. This report provides an in-depth analysis of competitive dynamics changes.

2. It offers an in-depth view of market growth and the factors limiting it.

3. It includes a six-year forecast based on market growth.

4. It helps to understand the key product categories and their future.

5. It offers a detailed analysis of changes in competition dynamics that will keep you ahead of your peers

Get instant access or purchase this premium market report Cancer Biological Therapy:

The report answers such questions as:

1. What is the market size for Cancer Biological Therapy and its forecast?

2. What are the limiting factors and the impact of COVID-19 in shaping the Global Cancer Biological Therapy Market?

3. Which products/segments/applications/areas to invest in over the Global Cancer Biological Therapy Market forecast period?

4. What is the Global Cancer Biological Therapy Market’s strategic competitive window for new opportunities?

5. What technology trends are there in the Global Cancer Biological Therapy Market?

6. What is the market size of the most prominent vendors in the Global Cancer Biological Therapy Marketplace?

7. What strategic moves and methods are appropriate for entry into the Global Cancer Biological Therapy Market?


Angiopoietin 2 Recent Development with Covid-19 Effect Analysis by Top Companies in 2022

EMS Products Competitive Strategies along with Factors Contributing To Growth And Forecast up to 2031

Electroceuticals/Bioelectric Medicine 2022 Research Analysis, Strategic Insights, and Forecast to 2031

About is a top market research firm that offers industry expertise and expert consulting services for clients to improve their business development. provides reports and services used globally by start-ups, prestigious academic institutions, and multinational companies to understand and measure changes in regional and international business backgrounds.

Communication contact:

Global Business Development Teams – (Powered By Prudour Pvt. Ltd.)

For Sales Enquiries:

Address: 420 Lexington Avenue, Suite 300, New York City, NY 10170, United States

Tel: +1 718 618 4351


This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 09-Nov-2022